| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
Morantel targets nicotinic acetylcholine receptors (nAChRs) on nematode muscle cells. It acts as a high-efficacy agonist, more potent than acetylcholine at alpha-7 nAChRs. The EC50 for morantel activation of alpha-7 and alpha-7-5HT3A receptors is 7-fold lower than that of acetylcholine. It also targets levamisole-sensitive nAChR channels, acting as an open channel blocker.
|
|---|---|
| ln Vitro |
Morantel is a potent agonist at nematode acetylcholine receptors. It exhibits high efficacy and potency at alpha-7 nAChRs, with EC50 values lower than acetylcholine. In nematode AChRs, morantel EC50 values range from 0.98 μM to 29.0 μM depending on the receptor subtype. It induces prolonged spastic paralysis of worms.
|
| ln Vivo |
In vivo, morantel is effective against gastrointestinal nematodes in livestock. It is administered orally to pigs, cattle, and sheep, causing expulsion of roundworms and tapeworms. The compound is used as a tartrate or citrate salt in feed or drinking water.
|
| Enzyme Assay |
The nAChR binding assay uses membranes from nematode muscle cells or cells expressing recombinant nAChRs. Morantel is serially diluted and incubated with membranes and a radiolabeled ligand such as [3H]epibatidine. Bound radioactivity is separated by filtration and quantified.
|
| Cell Assay |
For functional assays, Xenopus oocytes expressing nematode nAChRs are used. Morantel is applied, and currents are measured using two-electrode voltage-clamp electrophysiology. Dose-response curves are generated to determine EC50 values.
|
| Animal Protocol |
For in vivo studies, morantel is administered orally to infected livestock. Fecal egg counts are performed to assess anthelmintic efficacy. Worm burdens are determined by necropsy. The compound is also used as a feed additive for prevention of nematode infections.
|
| References | |
| Additional Infomation |
1-Methyl-2-[2-(3-methyl-2-thienyl)vinyl]-5,6-dihydro-4H-pyrimidine is a pyrimidine compound. It is primarily used as an anti-nematode drug for livestock. See also: Morant tartrate (in salt form); Morant citrate (its active ingredient).
|
| Molecular Formula |
C12H16N2S
|
|---|---|
| Molecular Weight |
220.33384
|
| Exact Mass |
220.103
|
| CAS # |
20574-50-9
|
| Related CAS # |
20574-50-9;26155-31-7 (tartrate);
|
| PubChem CID |
5353792
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1.11g/cm3
|
| Boiling Point |
334.6ºC at 760mmHg
|
| Flash Point |
156.1ºC
|
| Vapour Pressure |
1.98E-13mmHg at 25°C
|
| LogP |
2.177
|
| tPSA |
43.84
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
15
|
| Complexity |
273
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
C1(SC=CC=1C)/C=C/C1=NCCCN1C
|
| InChi Key |
NVEPPWDVLBMNMB-SNAWJCMRSA-N
|
| InChi Code |
InChI=1S/C12H16N2S/c1-10-6-9-15-11(10)4-5-12-13-7-3-8-14(12)2/h4-6,9H,3,7-8H2,1-2H3/b5-4+
|
| Chemical Name |
1-methyl-2-[(E)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4H-pyrimidine
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.5386 mL | 22.6932 mL | 45.3865 mL | |
| 5 mM | 0.9077 mL | 4.5386 mL | 9.0773 mL | |
| 10 mM | 0.4539 mL | 2.2693 mL | 4.5386 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.